Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid

Thrombosis Research
P MinuzL Cuzzolin

Abstract

We studied in vitro the effects on platelet aggregation and vascular tone of a new nitrocompound (nitroxy-butyl-acetylsalicylate: NO-ASA). In order to elucidate any possible activity due to the release of nitric oxide or the inhibition of platelet cyclo-oxygenase we compared NO-ASA to acetylsalicylic acid. NO-ASA 1 mM inhibited arachidonic acid-induced platelet aggregation (basal 75.4 +/- 2.35%; NO-ASA 22 +/- 3.46%; M +/- SEM; P < 0.001; n = 6), but proved less active than acetylsalicylic acid (complete inhibition at 2 x 10(-5) M). NO-ASA also significantly reduced thrombin-induced (0.04-0.08 U/ml) platelet aggregation in acetylsalicylic acid-treated platelets (basal 70.5 +/- 1.7%; NO-ASA 35.4 +/- 2.2%; P < 0.001; n = 10; IC50 7 x 10(-5) M). Methylene blue reduced the effects of NO-ASA on thrombin-induced (NO-ASA 46.7 +/- 5.25%; NO-ASA+MB 59.1 +/- 4.3%; P < 0.01; n = 8), but not arachidonic acid-induced platelet aggregation. The inhibitory effects of NO-ASA on platelet aggregation were partially removed by oxyhaemoglobin. Platelet thromboxane A2 production (TXB2 concentration in the supernatant of the aggregate 35.38 +/- 7.81 ng/ml; n = 8), was totally abolished by acetylsalicylic acid (0.17 +/- 0.04 ng/ml; P < 0.001; n = 8) an...Continue Reading

References

Feb 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiJ Vane
Oct 15, 1991·Biochemical and Biophysical Research Communications·M Feelisch, M Kelm
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiJ Vane
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·R F Furchgott
Mar 1, 1983·Hypertension·E G SpokasJ C McGiff
Jul 1, 1994·Trends in Pharmacological Sciences·B M BennettW C Simon
Jan 20, 1994·Nature·J Vane

❮ Previous
Next ❯

Citations

Jul 10, 1999·Toxicon : Official Journal of the International Society on Toxinology·S A AliD Shehnaz
Apr 9, 2002·Prostaglandins & Other Lipid Mediators·Chatargy S KazaBasil Rigas
Aug 4, 1999·Trends in Pharmacological Sciences·P del SoldatoA Pinto
Jul 6, 2000·Bioorganic & Medicinal Chemistry·Z GuoR Gollamudi
Jul 9, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·S Fiorucci, P Del Soldato
Feb 2, 2010·Nature Reviews. Drug Discovery·Alan D Michelson
Jul 18, 2002·Nature Reviews. Drug Discovery·John L WallaceStefano Fiorucci
May 17, 2006·British Journal of Pharmacology·Catriona M TurnbullIan L Megson
Dec 23, 2016·Medicinal Research Reviews·Catarina Pereira-LeiteSalette Reis
Sep 1, 2007·Archiv der Pharmazie·Ana C Montes-GilGilberto de Nucci
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Catriona M TurnbullIan L Megson
May 26, 2005·Pharmacological Reviews·Vincenzo MollaceDaniela Salvemini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.